The PDGFRβ-AKT pathway contributes to CDDP-acquired resistance in testicular germ cell tumors.
about
C-Jun N-terminal kinase signalling pathway in response to cisplatinNext generation sequencing analysis of platinum refractory advanced germ cell tumor sensitive to Sunitinib (Sutent®) a VEGFR2/PDGFRβ/c-kit/ FLT3/RET/CSF1R inhibitor in a phase II trialTDRG1 regulates chemosensitivity of seminoma TCam-2 cells to cisplatin via PI3K/Akt/mTOR signaling pathway and mitochondria-mediated apoptotic pathway.The Role of PDGFR-β Activation in Acquired Resistance to IGF-1R Blockade in Preclinical Models of Rhabdomyosarcoma.Cisplatin resistance in germ cell tumours: models and mechanisms.Platelet-derived growth factor (PDGF) signalling in cancer: rapidly emerging signalling landscape.Pharmacotherapeutic treatment of germ cell tumors: standard of care and recent developments.Patient-derived xenografts for childhood solid tumors: a valuable tool to test new drugs and personalize treatments.Postchemotherapy changes in testicular germ cell tumours: biology and morphology.Investigational targeted therapies for the treatment of testicular germ cell tumors.Platinum-refractory germ cell tumors: an update on current treatment options and developments.IGF1R signalling in testicular germ cell tumour cells impacts on cell survival and acquired cisplatin resistance.Exploring the molecular aspects associated with testicular germ cell tumors: a review.Epigenetic traits of testicular cancer: from primordial germ cells to germ cell tumors.EGF Receptor and mTORC1 Are Novel Therapeutic Targets in Nonseminomatous Germ Cell Tumors.Molecular biology of testicular germ cell tumors.Impact of p53 and PDGFR-β Expression on Metastasis and Prognosis of Patients with Pancreatic Cancer.Key Players of Cisplatin Resistance: Towards a Systems Pharmacology Approach.
P2860
Q26745463-501770E6-149A-4B2A-94CC-4F37932E74C4Q34544846-D945B3A6-4C1B-4BDD-A7BE-BE7E58D72085Q37146304-CCBD4801-59D2-4DC9-A1EC-B6C17957BF4AQ37421580-5B24ECEA-F0A7-4B3B-950E-1CCE8B7FF09FQ38302534-17ED0619-EC6C-4BAC-B720-C56C0CFCBA66Q38543837-8BBC2000-B571-47D7-B701-7DC9B17EF7ABQ38656908-46F2A6B4-160F-4CAF-91A0-9D2AD3EE2787Q38741974-0E6F9D97-D141-4BF7-AC36-2140F505191EQ38783396-AD538B51-8400-46D5-8F07-F2D1508C66E5Q38861307-6E3E099C-D2DE-4A5F-AAAC-F1AE36B55FA6Q38906007-FC885BC6-B7CE-4605-A93A-1322B31423E4Q48262511-35578C82-E933-46F1-9513-FA816EA6CE3CQ49610684-6468F2AF-B341-401D-ABEE-6D2B28D47D29Q52652741-FDEA9FC8-1594-440E-9FDF-5DC1B2A66A78Q52684455-1F153E58-C0D7-466F-B32A-46A15002204DQ53813048-9EEC492F-DD57-4C6B-9551-5D375D7769AAQ54210630-D4C895F0-10CE-445D-B334-A1B03755F1A5Q54259614-C44A0580-A88D-4941-AEE7-A0603FEC5A80
P2860
The PDGFRβ-AKT pathway contributes to CDDP-acquired resistance in testicular germ cell tumors.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
The PDGFRβ-AKT pathway contrib ...... n testicular germ cell tumors.
@en
The PDGFRβ-AKT pathway contrib ...... n testicular germ cell tumors.
@nl
type
label
The PDGFRβ-AKT pathway contrib ...... n testicular germ cell tumors.
@en
The PDGFRβ-AKT pathway contrib ...... n testicular germ cell tumors.
@nl
prefLabel
The PDGFRβ-AKT pathway contrib ...... n testicular germ cell tumors.
@en
The PDGFRβ-AKT pathway contrib ...... n testicular germ cell tumors.
@nl
P2093
P50
P1476
The PDGFRβ-AKT pathway contrib ...... n testicular germ cell tumors.
@en
P2093
A Villanueva
C A Moutinho
M Juliachs
P304
P356
10.1158/1078-0432.CCR-13-1131
P407
P577
2013-11-25T00:00:00Z